ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — GlycoMimetics Inc. (GLYC) on Wednesday reported a loss of $9.8 million in its third quarter. On a per-share basis, the Rockville, Maryland-based ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of GlycoMimetics, Inc. (NASDAQ: GLYC) and Crescent Biopharma, Inc. is fair to ...
GlycoMimetics ( (GLYC) ) has issued an update. GlycoMimetics, Inc. has announced a merger with Crescent Biopharma, aiming to enhance their presence in the biopharma sector. This merger ...
We are headquartered at the Empire State Building in New York City and are investigating GlycoMimetics, Inc. (NASDAQ: GLYC), relating to a proposed merger with First Crescent Biopharma ...
INVESTIGATION ALERT: The M&A Class Action Firm Investigates The Merger Of Glycomimetics, Inc. - GLYC
Our firm litigates and has recovered money for shareholders...and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track ...
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and ...
GLYC) announced today it has entered into an acquisition agreement with Crescent Biopharma, Inc. (“Crescent”), a privately held biotechnology company advancing a pipeline of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback